We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

3 hedge funds and large institutions have $781K invested in BioCardia, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

11% less capital invested

Capital invested by funds: $879K → $781K (-$98K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.58K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$12.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
1
CAPTRUST Financial Advisors
North Carolina
$690K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$74K -$12.7K -8,235 -13%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$17K +$2.58K +1,675 +16%

BCDAW Hedge Fund Activity: Q1 2021 in Review

3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q1 2021, worth a combined $781K — down 11% from $879K a quarter earlier.

Fund positioning in BCDAW was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $2.58K. The largest seller was Osaic Holdings, cutting an estimated $12.7K.

  • 3 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $781K of BioCardia, Inc. Warrant stock for Q1 2021, down 11% quarter-over-quarter.
  • 0 funds opened new BioCardia, Inc. Warrant positions in Q1 2021 and 0 closed out.
  • The largest BioCardia, Inc. Warrant buyer in Q1 2021 was Susquehanna International Group, an estimated $2.58K added.
  • The largest BioCardia, Inc. Warrant seller in Q1 2021 was Osaic Holdings, an estimated $12.7K sold.

Based on aggregated 13F filings for Q1 2021.